Corbevax gets approval as heterogenous vax, but isn't listed on CoWin

Company had issued a press release on June 4 where it said DCGI has approved Corbevax as a heterologous Covid booster dose to individuals aged 18 and above after 6 months of primary vaccination

The National Technical Advisory Group of Immunisation (NTAGI) is yet to review any data on using Corbevax as a heterologous booster shot after two doses of Covishield or Covaxin, sources revealed. The vaccine, which was approved as a heterologous booster by the Drugs Controller General of India (DCGI), is thus not yet available on Co-WIN as an option for precaution shots. 

A senior member of the NTAGI said the Union Ministry of Health decides the agenda for meetings, and the matters that need NTAGI review. “The health ministry has not yet asked us to look into the matter of Biological